BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38745046)

  • 1. EP4-induced mitochondrial localization and cell migration mediated by CALML6 in human oral squamous cell carcinoma.
    Ishikawa S; Umemura M; Nakakaji R; Nagasako A; Nagao K; Mizuno Y; Sugiura K; Kioi M; Mitsudo K; Ishikawa Y
    Commun Biol; 2024 May; 7(1):567. PubMed ID: 38745046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E
    Osawa K; Umemura M; Nakakaji R; Tanaka R; Islam RM; Nagasako A; Fujita T; Yokoyama U; Koizumi T; Mitsudo K; Ishikawa Y
    Cancer Sci; 2020 Jan; 111(1):160-174. PubMed ID: 31755615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
    Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
    Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of prostaglandin E2 receptors in oral squamous cell carcinomas and growth inhibitory effects of an EP3 selective antagonist, ONO-AE3-240.
    Hoshikawa H; Goto R; Mori T; Mitani T; Mori N
    Int J Oncol; 2009 Mar; 34(3):847-52. PubMed ID: 19212690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
    Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
    Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EP4 antagonist, L-161,982, induces apoptosis, cell cycle arrest, and inhibits prostaglandin E2-induced proliferation in oral squamous carcinoma Tca8113 cells.
    Li X; Yang B; Han G; Li W
    J Oral Pathol Med; 2017 Nov; 46(10):991-997. PubMed ID: 28342204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
    Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
    Prgomet Z; Axelsson L; Lindberg P; Andersson T
    J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma.
    Kayamori K; Katsube KI; Hirai H; Harada H; Ikeda T
    Lab Invest; 2023 Oct; 103(10):100228. PubMed ID: 37541622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
    Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
    Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma.
    Sun LP; Xu K; Cui J; Yuan DY; Zou B; Li J; Liu JL; Li KY; Meng Z; Zhang B
    Oncol Rep; 2019 Oct; 42(4):1319-1328. PubMed ID: 31364748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
    Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
    Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
    Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating the ERK1/2-MMP1 Axis through Corosolic Acid Inhibits Metastasis of Human Oral Squamous Cell Carcinoma Cells.
    Chen JL; Lai CY; Ying TH; Lin CW; Wang PH; Yu FJ; Liu CJ; Hsieh YH
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.